🕒 Last update: loading…09/11/2026

Stock Intrasense S.A. ALINS.PA

Intrasense S.A. — Investlytic score 0/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 0/5 criteria met. Data as of 01/11/2026.

  • ❌ Price trend failed
  • ❌ Growth failed
  • ❌ Debt failed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2018 → 2019: 22.57%

Price change 2019 → 2020: 315.86%

Price change 2020 → 2021: -47.40%

Price change 2021 → 2022: -38.29%

Price change 2022 → 2023: 11.11%

Price change 2023 → 2024: -35.83%

Price change 2024 → 2025: -0.87%

Price change 2025 → 2026: -10.48%

Price change 2026 (year to date): -10.48%

Financial growth

Revenue CAGR (8 years): -3.38%

Earnings CAGR (8 years): N/A

Growth status: insufficient data or negative trend.

Debt

Negative or zero equity.

P/E (Price/Earnings)

P/E ratio: -0.95

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 49.88% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Intrasense S.A.––+7.3 %🔒
Aelis Farma S.A.–1.49+49.1 %–
SpineGuard S.A.–0.27+1.6 %–
Biosynex S.A.–1.90+35.4 %–
Valbiotis S.A.–0.73+56.9 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Intrasense S.A. over the latest fiscal years.

Revenue
3.3 m USD
fiscal year 2025
Net income
-12.1 m USD
fiscal year 2025
Net margin
-364.8 %
fiscal year 2025
Average annual growth
-2.9 %
Revenue growth over 5 years
Average annual growth
-1.9 %
Revenue growth over 10 years
Market cap
12.1 m USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
20203.8 m-784,861-20.5 %n/a
20214.7 m-1.3 m-28.7 %+21.7 %
20224.2 m-3.8 m-90.2 %-9.5 %
20233.7 m-4.0 m-108.3 %-12.8 %
20242.5 m-6.3 m-251.8 %-32.0 %
20253.3 m-12.1 m-364.8 %+31.9 %

Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Intrasense S.A. over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
-13.56
risk zone (below 1.81)
Piotroski Score
1 / 9
0 to 3: fragile accounts
Net Debt / EBITDA
0.03 x
low debt
Fiscal year20212022202320242025
Cash and investments4.8 m1.4 m4.6 m930,000797,458
Total Debt1.9 m2.1 m1.5 m1.6 m500,381
Net Debt117,000650,000-3.1 m654,000-297,077
Equity5.0 m2.0 m7.3 m1.7 m-6.5 m
Total assets8.8 m6.5 m10.5 m7.7 m8.0 m
Operating cash flow-903,000-2.0 m-3.0 m-3.7 mn/a
Investments (capex)554,0001.5 m1.9 m2.2 mn/a
Free cash-flow-1.5 m-3.5 m-5.0 m-5.9 mn/a
Share buybacks0000n/a
Dividends paid0000n/a

Amounts in EUR, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)-0.76 x
Price / book value-0.85 x
Return on Equity (ROE)148.6 %
Return on Invested Capital (ROIC)122.6 %
Net margin-713.9 %
Debt / equity-0.05 x
Current ratio0.18 x
Interest coverage-19.03 x
Free cash-flow yield-33.8 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.

+

Dividends and earnings

Intrasense S.A.: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Stock splits

DateOperation
26/05/2021split: 1,031 shares for 1,000

Factual data: ex-dividend history and earnings calendar, as of 05/11/2026. A past dividend does not guarantee the next one.

+

PEA and practical information

PEA eligibility
likely
head office in the EU or EEA, listed on a European exchange
Listing exchange
Euronext Paris
IPO: 22/02/2012
ISIN code
FR0011179886
Workforce
76
full-time employees
Chief executive
Alexandre Salvador

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Intrasense S.A.

What is the Intrasense S.A. share price?

Latest recorded price: 0.206 EUR on 06/11/2026, for a market cap of 12.1 m USD.

What is the revenue of Intrasense S.A.?

3.3 m USD for fiscal year 2025, with net income of -12.1 m USD (net margin -364.8 %).

Is Intrasense S.A. stock eligible for the French PEA?

Likely: the company is headquartered in the European Union or the European Economic Area (ISIN FR0011179886) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.

How many employees does Intrasense S.A. have?

76 full-time employees according to the latest published profile.

Who runs Intrasense S.A.?

Alexandre Salvador is the company's chief executive.

07

Similar stocks